Long-Term Endoscopic Follow-Up of Patients with Chronic Radiation Proctopathy after Brachytherapy for Prostate Cancer

Table 1

Patient characteristics.

Characteristic
Number of patients	104
Age, mean ± SD	68.1 ± 6.6
Clinical stage, (%)
T1c	81 (77.8)
T2a	16 (15.4)
T2b	4 (3.8)
T2c	3 (2.9)
Use of antithrombotic drugs (%)	21 (20.2)
Presence of DM (%)	12 (11.5)
Volume of prostate, (cc) mean ± SD	25.6 ± 8.3
Treatment
EBRT boost (%)	53 (51.0)
Median dose of EBRT (range)	45 (43–55.6)
Median number of seeds (range)	70 (40–100)
ADT (%)	39 (37.5)

DM, diabetes mellitus; EBRT, external-beam radiotherapy; ADT, androgen deprivation therapy.